Determination of infundibular innervation and amine receptor content in cyanotic and acyanotic myocardium: relation to clinical events in tetralogy of Fallot.
Right ventricular myocardium was assessed for cholinergic and adrenergic innervation, as well as alpha-adrenergic, beta-adrenergic, and muscarinic receptors, in 18 cyanotic patients with tetralogy of Fallot (TOF) and four acyanotic control patients with ventricular septal defect, each of whom underwent a cardiac repair from June through December 1987. Neurons containing acetylcholine (ACH), neuron-specific enolase (NSE), S-100 protein, neuropeptide-Y (NPY), dopamine-beta-hydroxylase (DBH), and calcitonin gene-related polypeptide (CGRP) were detected surrounding arterioles and myocytes in all specimens. NSE and S-100 immunoreactivities were also identified in the cytoplasm of TOF cardiocytes, possibly indicating a neuroendocrine origin of these cells. Cardiocyte size was increased in TOF (p = 0.05). Acetylcholine (cholinergic) (p = 0.04) and CGRP (cholinergic) positive neurons (p = 0.07) were decreased in the TOF as compared to controls. Adrenergic fiber content (p = 0.15) and beta receptors (p = 0.21) were similar in both groups. There was an increase in muscarinic receptors in the controls (p = 0.002), and a marked increase in alpha receptors in TOF (p = 0.019). There were no intragroup differences in the TOF patients according to degree of cyanosis. In conclusion, there were important differences in neuronal and amine receptor content between TOF and control patients. Increased alpha receptors in TOF could account for differences in clinical and hemodynamic events.
McGrath
L B
LB
Department of Surgery, Deborah Heart and Lung Center, Browns Mills, New Jersey 08015.
Chen
C
C
Gu
J
J
Bianchi
J
J
Levett
J M
JM
D000109:Acetylcholine / Q000737:chemistry; D015740:Calcitonin Gene-Related Peptide / Q000737:chemistry; D003490:Cyanosis / Q000209:etiology*; D004299:Dopamine beta-Hydroxylase / Q000737:chemistry; D005260:Female; D006345:Heart Septal Defects, Ventricular / Q000473:pathology*; D006352:Heart Ventricles / Q000737:chemistry* / Q000294:innervation; D006801:Humans; D007223:Infant; D008297:Male; D009206:Myocardium / Q000737:chemistry*; D009474:Neurons / Q000737:chemistry*; D009478:Neuropeptide Y / Q000737:chemistry; D010751:Phosphopyruvate Hydratase / Q000737:chemistry; D011942:Receptors, Adrenergic, alpha / Q000737:chemistry*; D011943:Receptors, Adrenergic, beta / Q000737:chemistry*; D011976:Receptors, Muscarinic / Q000737:chemistry*; D009418:S100 Proteins / Q000737:chemistry; D013771:Tetralogy of Fallot / Q000150:complications / Q000473:pathology* / Q000503:physiopathology
D009478:Neuropeptide Y; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D011976:Receptors, Muscarinic; D009418:S100 Proteins; D004299:Dopamine beta-Hydroxylase; D010751:Phosphopyruvate Hydratase; D015740:Calcitonin Gene-Related Peptide; D000109:Acetylcholine